⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6255677 | 0.93 | — | — | |
| SCHEMBL6255674 | 0.93 | — | — | |
| SCHEMBL6258446 | 0.80 | — | — | |
| SCHEMBL6258448 | 0.80 | — | — | |
| SCHEMBL28685175 | 0.76 | — | — | |
| SCHEMBL6898200 | 0.74 | HRH3 (0.38) | — | |
| SCHEMBL15183667 | 0.70 | ALDH1A1 (0.32) | — | |
| SCHEMBL6893076 | 0.69 | CYP3A4 (0.46) | — | |
| SCHEMBL6258539 | 0.69 | MEN1 (0.38) | — | |
| SCHEMBL18023048 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2004529069-A | — | — | 2004-09-24 | — | — | JP | claimed |
| EP-1351916-A2 | ETHER COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES | Esperion Therapeutics Inc. (US) | 2003-10-15 | — | — | EP | claimed |
| WO-2002030863-A2 | ETHER COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES | ESPERION THERAPEUTICS, INC. (US) | 2002-04-18 | — | — | WO | claimed |